Literature DB >> 15770005

Risk of cardiac death after adjuvant radiotherapy for breast cancer.

Sharon H Giordano1, Yong-Fang Kuo, Jean L Freeman, Thomas A Buchholz, Gabriel N Hortobagyi, James S Goodwin.   

Abstract

BACKGROUND: Women with breast cancer who are treated with adjuvant radiation have a decreased risk of local recurrence but an increased risk of mortality from ischemic heart disease. Patients with left-sided breast tumors receive a higher dose of radiation to the heart than patients with right-sided tumors. Because radiation techniques have improved over time, we investigated whether the risk of death from ischemic heart disease after adjuvant breast radiotherapy decreased over time.
METHODS: We used the 12-registry 1973-2000 dataset from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program. Women (n = 27,283) treated with adjuvant radiation for breast cancer diagnosed in 1973-1989 were included in the study. Ischemic heart disease mortality was calculated at 15 years and compared for women diagnosed during 1973-1979, 1980-1984, and 1985-1989. Cox proportional hazards models were used to calculate the hazard of death from ischemic heart disease for women diagnosed 1973-1988 and censored at 12 years. All statistical tests were two-sided.
RESULTS: There were no differences in age, race/ethnicity, disease stage, or follow-up time between the 13 998 women with left-sided and 13 285 with right-sided cancer. For women diagnosed in 1973-1979, there was a statistically significant difference in 15-year mortality from ischemic heart disease between patients with left-sided (13.1%, 95% confidence interval [CI] = 11.6 to 14.6) and those with right-sided (10.2%, 95% CI = 8.9 to 11.5) breast cancer (P = .02); no such difference was found for women diagnosed in 1980-1984 (9.4%, [95% CI = 8.1 to 10.6] versus 8.7% [95% CI = 7.4 to 10.0], respectively, P = .64) or 1985-1989 (5.8% [95% CI = 4.8 to 6.8] versus 5.2% [95% CI = 4.4 to 5.9], respectively, P = .98). In the Cox model, the hazard ratio [HR] for ischemic heart disease mortality for women with left-sided versus women with right-sided disease was 1.50 (95% CI = 1.19 to 1.87) in 1979. With each succeeding year after 1979, the hazard of death from ischemic heart disease for women with left-sided versus those with right-sided disease declined by 6% (HR = 0.94, 95% CI = 0.91 to 0.98).
CONCLUSIONS: Risk of death from ischemic heart disease associated with radiation for breast cancer has substantially decreased over time.

Entities:  

Mesh:

Year:  2005        PMID: 15770005      PMCID: PMC1853253          DOI: 10.1093/jnci/dji067

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  29 in total

1.  Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

Authors: 
Journal:  Lancet       Date:  2000-05-20       Impact factor: 79.321

2.  Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90 000 Swedish women.

Authors:  Sarah Darby; Paul McGale; Richard Peto; Fredrik Granath; Per Hall; Anders Ekbom
Journal:  BMJ       Date:  2003-02-01

3.  Assessment of coronary heart disease morbidity and mortality after radiation therapy for early breast cancer.

Authors:  Katherine A Vallis; Melania Pintilie; Nelson Chong; Eric Holowaty; Pamela S Douglas; Peter Kirkbride; Andreas Wielgosz
Journal:  J Clin Oncol       Date:  2002-02-15       Impact factor: 44.544

4.  Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials. Radiotherapy Committee of the Danish Breast Cancer Cooperative Group.

Authors:  I Højris; M Overgaard; J J Christensen; J Overgaard
Journal:  Lancet       Date:  1999-10-23       Impact factor: 79.321

5.  Trends in, and predictors of, breast-conserving surgery and radiotherapy for breast cancer in Connecticut, 1988-1997.

Authors:  Anthony P Polednak
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-05-01       Impact factor: 7.038

6.  Death certification and coding for ischemic heart disease in Australia.

Authors:  A J Dobson; R W Gibberd; S R Leeder
Journal:  Am J Epidemiol       Date:  1983-04       Impact factor: 4.897

7.  Information on radiation treatment in patients with breast cancer: the advantages of the linked medicare and SEER data. Surveillance, Epidemiology and End Results.

Authors:  X Du; J L Freeman; J S Goodwin
Journal:  J Clin Epidemiol       Date:  1999-05       Impact factor: 6.437

8.  Symptomatic cardiac events following radiation therapy for left-sided breast cancer: possible association with radiation therapy-induced changes in regional perfusion.

Authors:  Xiaoli Yu; Robert R Prosnitz; Sumin Zhou; Patricia H Hardenberg; Andrea Tisch; Michael A Blazing; Salvador Borges-Neto; Donna Hollis; Terence Wong; Lawrance B Marks
Journal:  Clin Breast Cancer       Date:  2003-08       Impact factor: 3.225

9.  Myocardial perfusion changes in patients irradiated for left-sided breast cancer and correlation with coronary artery distribution.

Authors:  Pehr A Lind; Robert Pagnanelli; Lawrence B Marks; Salvador Borges-Neto; Caroline Hu; Su Min Zhou; Kim Light; Patricia H Hardenbergh
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-03-15       Impact factor: 7.038

10.  Studying radiation therapy using SEER-Medicare-linked data.

Authors:  Beth A Virnig; Joan L Warren; Gregory S Cooper; Carrie N Klabunde; Nicola Schussler; Jean Freeman
Journal:  Med Care       Date:  2002-08       Impact factor: 2.983

View more
  123 in total

1.  Meta-analysis as a manifestation of 'bondförnuft' ('peasant sense').

Authors:  Jan Stjernswärd
Journal:  J R Soc Med       Date:  2010-07       Impact factor: 5.344

Review 2.  Exercise therapy in the management of solid tumors.

Authors:  Lee W Jones; Jeffrey Peppercom; Jessica M Scott; Claudio Battaglini
Journal:  Curr Treat Options Oncol       Date:  2010-06

3.  Six-year experience routinely using moderate deep inspiration breath-hold for the reduction of cardiac dose in left-sided breast irradiation for patients with early-stage or locally advanced breast cancer.

Authors:  Todd Swanson; Inga S Grills; Hong Ye; Amy Entwistle; Melanie Teahan; Nicola Letts; Di Yan; Joana Duquette; Frank A Vicini
Journal:  Am J Clin Oncol       Date:  2013-02       Impact factor: 2.339

4.  Long-Term Pulmonary Outcomes of a Feasibility Study of Inverse-Planned, Multibeam Intensity Modulated Radiation Therapy in Node-Positive Breast Cancer Patients Receiving Regional Nodal Irradiation.

Authors:  Alice Y Ho; Ase Ballangrud; Guang Li; Gaorav P Gupta; Beryl McCormick; Richard Gewanter; Daphna Gelblum; Melissa Zinovoy; Boris Mueller; Borys Mychalczak; Pinaki Dutta; Karen Borofsky; Preeti Parhar; Marsha Reyngold; Lior Z Braunstein; Mohit Chawla; Kate Krause; Natasha Freeman; Chun Ting Siu; Zachary Cost; Brittany B Arnold; Zhigang Zhang; Simon N Powell
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-11-30       Impact factor: 7.038

5.  Helical tomotherapy in patients with breast cancer and complex treatment volumes.

Authors:  Ricardo Cendales; Luis Schiappacasse; Franco Schnitman; Graciela García; Hugo Marsiglia
Journal:  Clin Transl Oncol       Date:  2011-04       Impact factor: 3.405

Review 6.  Postmastectomy radiotherapy in intermediate-risk patients: the gray zone.

Authors:  Carolyn I Sartor
Journal:  Curr Oncol Rep       Date:  2006-01       Impact factor: 5.075

7.  Comparison between intensity modulated radiotherapy (IMRT) and 3D tangential beams technique used in patients with early-stage breast cancer who received breast-conserving therapy.

Authors:  Beata Sas-Korczyńska; Anna Sladowska; Bożena Rozwadowska-Bogusz; Sonia Dyczek; Jan Lesiak; Anna Kokoszka; Stanisław Korzeniowski
Journal:  Rep Pract Oncol Radiother       Date:  2010-08-04

8.  Long-term follow-up for cardiovascular disease after chemotherapy and/or radiotherapy for breast cancer in an unselected population.

Authors:  L M Boerman; A J Berendsen; P van der Meer; J H Maduro; M Y Berger; G H de Bock
Journal:  Support Care Cancer       Date:  2014-03-02       Impact factor: 3.603

9.  The clinical implications of myocardial perfusion abnormalities in patients with esophageal or lung cancer after chemoradiation therapy.

Authors:  Isis Gayed; Salman Gohar; Zhongxing Liao; Mary McAleer; Roland Bassett; Syed Wamique Yusuf
Journal:  Int J Cardiovasc Imaging       Date:  2009-02-22       Impact factor: 2.357

10.  Quality of life of women treated with radiotherapy for breast cancer.

Authors:  T S Lee; S L Kilbreath; K M Refshauge; S C Pendlebury; J M Beith; M J Lee
Journal:  Support Care Cancer       Date:  2007-09-18       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.